Search Results - "Shao, Ruoyang"

ATXN2L upregulated by epidermal growth factor promotes gastric cancer cell invasiveness and oxaliplatin resistance by Lin, Li, Li, Xiaoyin, Pan, Changqie, Lin, Wanying, Shao, Ruoyang, Liu, Yantan, Zhang, Junhao, Luo, Yuhao, Qian, Kai, Shi, Min, Bin, Jianping, Liao, Yulin, Liao, Wangjun

“…For gastric cancer (GC) control, metastasis and chemoresistance are the major challenges, accompanied with various stresses. Ataxin-2-like (ATXN2L) was…”
Get full text

Engineering macrophages to phagocytose cancer cells by blocking the CD47/SIRPɑ axis by Yang, Hongcheng, Shao, Ruoyang, Huang, Hongxin, Wang, Xinlong, Rong, Zhili, Lin, Ying

“…The use of immunotherapy has achieved great advances in the treatment of cancer. Macrophages play a pivotal role in the immune defense system, serving both as…”
Get full text

Venetoclax Combined with Azacitidine and Homoharringtonine in Relapsed/Refractory AML: A Multicenter, Phase 2 Trial by Jin, Hua, Zhang, Yu, Yu, Sijian, Du, Xin, Xu, Na, Shao, Ruoyang, Lin, Dongjun, Chen, Yanqiu, Xiao, Jie, Sun, Zhiqiang, Deng, Lan, Liang, Xinquan, Zhang, Hongyu, Guo, Ziwen, Dai, Min, Shi, Pengcheng, Huang, Fen, Fan, Zhiping, Yin, Zhao, Xuan, Li, Lin, Ren, Jiang, Xuejie, Yu, Guopan, Liu, Qifa

“…Relapsed or refractory acute myeloid leukemia (R/R AML) has a dismal prognosis. The aim of this study was to investigate the activity and tolerability of…”
Get full text

Cell-cell contact-induced gene editing/activation in mammalian cells using a synNotch-CRISPR/Cas9 system by Huang, Hongxin, Zhang, Xin, Lv, Jie, Yang, Hongcheng, Wang, Xinlong, Ma, Shufeng, Shao, Ruoyang, Peng, Xin, Lin, Ying, Rong, Zhili

Get full text

Hepatic venous pressure gradient-guided laparoscopic splenectomy and pericardial devascularisation versus endoscopic therapy for secondary prophylaxis for variceal rebleeding in portal hypertension (CHESS1803): study protocol of a multicenter randomised controlled trial in China by Shao, Ruoyang, Li, Zhiwei, Wang, Jitao, Qi, Ruizhao, Liu, Qingbo, Zhang, Weijie, Mao, Xiaorong, Song, Xiaojing, Li, Lei, Liu, Yanna, Zhao, Xin, Liu, Chuan, Li, Xun, Zuo, Changzeng, Wang, Weidong, Qi, Xiaolong

“…IntroductionGastro-oesophageal variceal bleeding is one of the most common and severe complications with high mortality in cirrhotic patients who developed…”
Get full text

Impact of genetic patterns on sorafenib efficacy in patients with FLT3-ITD acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation: a multi-center, cohort study by Shao, Ruoyang, Zhang, Yu, He, Jinping, Huang, Fen, Fan, Zhiping, Yang, Kaibo, Xu, Yajing, Xu, Na, Luo, Yi, Deng, Lan, Zhang, Xi, Chen, Jia, Han, Mingzhe, Li, Xudong, Yu, Sijian, Liu, Hui, Liang, Xinquan, Luo, Xiaodan, Shi, Pengcheng, Wang, Zhixiang, Jiang, Ling, Zhou, Xuan, Lin, Ren, Chen, Yan, Tu, Sanfang, Sun, Jing, Wang, Yu, Liu, Qifa, Xuan, Li

“…Sorafenib therapy improves overall survival (OS) in patients with FLT3 internal tandem duplication (ITD) acute myeloid leukemia (AML) undergoing allogeneic…”
Get full text

The Presence of Ascites Affects the Predictive Value of HVPG on Early Rebleeding in Patients with Cirrhosis by Li, Xiaoguo, Wang, Jitao, Xu, Dan, Mao, Hua, Zhang, Chunqing, Qi, Xiaolong, Liang, Mingkai, Liu, Yanna, Zhang, Mingyan, Wang, Lifen, Wang, Guangchuan, Wang, Sining, Shao, Ruoyang, Liu, Chuan, Kang, Ning

“…Background and Aims. Gastroesophageal variceal bleeding is a serious complication of portal hypertension in cirrhotic patients and could be predicted by…”
Get full text

Mesenchymal Stromal Cell Infusion Might Improve Bronchiolitis Obliterans after Allogeneic Hematopoietic Stem Cell Transplantation and Modulate Alveolar Macrophages in Mice by Shao, Ruoyang, Liu, Qifa

“…Some studies suggested that mesenchymal stromal cell (MSC) infusion might improve bronchiolitis obliterans (BO) in patients who received allogeneic…”
Get full text

Impact of Concomitant Genetic Abnormalities on Sorafenib Therapy in FLT3-ITD Positive Acute Myeloid Leukemia Undergoing Allo-HSCT by Shao, Ruoyang, Liu, Qifa

“…Aim In this study, we investigated the co-occurring mutation landscape in acute myeloid leukemia (AML) patients with FLT3 internal tandem duplication…”
Get full text

Sorafenib Plus Triplet Therapy with Venetoclax, Azacitibine and Homoharringtonine for Refractory/Relapsed Acute Myeloid Leukemia with FLT3-ITD: A Multicentre, Phase 2 Study by Yu, Sijian, Liu, Qifa, Zhang, Yu, Yu, Guopan, Wang, Yu, Shao, Ruoyang, Liu, Qiong

“…Abstract Background Patients with relapsed or refractory acute myeloid leukemia (R/R AML) with FLT3 internal tandem duplication (FLT3-ITD) have an infrequent…”
Get full text

Comprehensive pan-cancer analysis of KLRB1-CLEC2D pair and identification of small molecule inhibitors to disrupt their interaction by Zhu, Yaoyao, Zhang, Huajie, Shao, Ruoyang, Wu, Xintong, Ding, Yike, Li, Yanzi, Wang, Weiwei, Li, Bingqing, Lu, Peiyuan, Ma, Zhongrui

“…•Higher CLEC2D/KLRB1 ratio is observed in most cancers compared to normal tissues.•CLEC2D and KLRB1 expression variation is mainly due to lymphocyte…”
Get full text

Comment on “Somatostatin as Inflow Modulator in Liver-transplant Recipients With Severe Portal Hypertension: A Randomized Trial” by Shao, Ruoyang, Liu, Chuan, Liu, Yanna, Mao, Hua, Li, Xun, Qi, Xiaolong

Get full text

Genetic characteristics predict response to venetoclax plus hypomethylating agents in relapsed or refractory acute myeloid leukemia by Weng, Guangyang, Zhang, Yu, Yu, Guopan, Luo, Tingyue, Yu, Sijian, Xu, Na, Sun, Zhiqiang, Lin, Dongjun, Deng, Lan, Liang, Xinquan, Xiao, Jie, Zhang, Hongyu, Guo, Ziwen, Shao, Ruoyang, Du, Xin, Jin, Hua, Liu, Qifa

“…Background The heterogeneity of relapsed or refractory (R/R) acute myeloid leukemia (AML) leads to no response to venetoclax (VEN)–based therapy in more than…”
Get full text

Nestin+ Mesenchymal Stromal Cells Fibrotic Transition Mediated by CD169+ Macrophages in Bone Marrow Chronic Graft-versus-Host Disease by Zhang, Haiyan, Liu, Jiapei, Sun, Yiming, Huang, Junwei, Qi, Hanzhou, Shao, Ruoyang, Wu, Qiaoyuan, Jiang, QianLi, Fu, Rong, Liu, Qifa, Jin, Hua

“…Abstract Chronic graft-versus-host disease (cGVHD) involves multiple organs, but little is known about bone marrow (BM) alterations caused by cGVHD. In mice…”
Get full text

Ruxolitinib versus basiliximab for steroid-refractory acute graft-versus-host disease: a retrospective study by Liu, Jiapei, Fan, Zhiping, Xu, Na, Ye, Jieyu, Chen, Yanqiu, Shao, Ruoyang, Sun, Yiming, Wu, Qiaoyuan, Liu, Qifa, Jin, Hua

“…Acute graft-versus-host disease (aGVHD) remains a major limitation of allogeneic hematopoietic stem cell transplantation; not all patients respond to standard…”
Get full text

Sorafenib plus triplet therapy with venetoclax, azacitidine and homoharringtonine for refractory/relapsed acute myeloid leukemia with FLT3‐ITD: A multicenter phase 2 study by Yu, Sijian, Zhang, Yu, Yu, Guopan, Wang, Yu, Shao, Ruoyang, Du, Xin, Xu, Na, Lin, Dongjun, Zhao, Weihua, Zhang, Xiong, Xiao, Jie, Sun, Zhiqiang, Deng, Lan, Liang, Xinquan, Zhang, Hongyu, Guo, Ziwen, Dai, Min, Shi, Pengcheng, Huang, Fen, Fan, Zhiping, Liu, Qiong, Lin, Ren, Jiang, Xuejie, Xuan, Li, Liu, Qifa, Jin, Hua

“…Background Patients with relapsed or refractory acute myeloid leukemia (R/R AML) and FLT3‐internal tandem duplication (FLT3‐ITD) respond infrequently to…”
Get full text

Sorafenib maintenance after allogeneic haemopoietic stem-cell transplantation in patients with FLT3-ITD acute myeloid leukaemia: long-term follow-up of an open-label, multicentre, randomised, phase 3 trial by Xuan, Li, Wang, Yu, Yang, Kaibo, Shao, Ruoyang, Huang, Fen, Fan, Zhiping, Chi, Peiru, Xu, Yajing, Xu, Na, Deng, Lan, Li, Xudong, Liang, Xinquan, Luo, Xiaodan, Shi, Pengcheng, Liu, Hui, Wang, Zhixiang, Jiang, Ling, Lin, Ren, Chen, Yan, Tu, Sanfang, Zhang, Yu, Sun, Jing, Huang, Xiaojun, Liu, Qifa

“…Our open-label, multicentre, randomised, phase 3 trial showed that sorafenib maintenance after haematopoietic stem-cell transplantation (HSCT) improved overall…”
Get full text

Prognostic impact of mutations on acute myeloid leukemia by Qiqi Tao, Qiaoyuan Wu, Yutong Xue, Changkun Chen, Ya Zhou, Ruoyang Shao, Haiyan Zhang, Hui Liu, Xiangzong Zeng, Lingling Zhou, Qifa Liu, Hua Jin

“…Background: Interleukin-7 receptor ( IL7R ) mutation has been demonstrated to be an adverse prognostic factor in acute lymphoblastic leukemia (ALL) patients…”
Get full text

PITPNC1 fuels radioresistance of rectal cancer by inhibiting reactive oxygen species production by Tan, Yujing, Shao, Ruoyang, Li, Jingyu, Huang, Hongyun, Wang, Yanru, Zhang, Menglan, Cao, Jianyun, Zhang, Junde, Bu, Junguo

“…Neoadjuvant radiotherapy is a commonly used method for the current standard-of-care for most patients with rectal cancer, when the effects of radioresistance…”
Get full text

Prognostic impact of IL7R mutations on acute myeloid leukemia by Tao, Qiqi, Wu, Qiaoyuan, Xue, Yutong, Chen, Changkun, Zhou, Ya, Shao, Ruoyang, Zhang, Haiyan, Liu, Hui, Zeng, Xiangzong, Zhou, Lingling, Liu, Qifa, Jin, Hua

“…Interleukin-7 receptor ( ) mutation has been demonstrated to be an adverse prognostic factor in acute lymphoblastic leukemia (ALL) patients. However, the…”
Get full text